Consistently, our data show that anti-CD40 main effect was to activate cross-presenting DCs at the irradiated tumor site and draining lymph node and promote the expansion of tumor-specific CD8+ T cells migrating between the dLN and the tumor in mice treated with RT+CTLA4i. This evidence concerns the gene CD8A and neoplasm.